Recent Press

Stay updated with the latest from ClexBio.

ClexBio wins the DNB Healthcare Prize 2022

ClexBio was selected to compete with 4 finalists and wins the 2022 DNB Healthcare Prize. The prize comes with a USD 100k check, which will continue to propel our pre-clinical program, and a showcase on the NASDAQ billboard on Times Square - auspice of bigger things to come.

Learn More

The EQT Foundation features ClexBio

EQT Foundation, part of EQT Group, publishes feature on ClexBio highlighting its innovative technology platform and the unique potential it has to revolutionize human tissue transplantation. EQT Group is one of the premier private equity and venture investment groups in the world and is one of Europe’s largest and most experienced healthcare investors.

Learn More

ClexBio Announces New Appointments to Board of Directors

ClexBio appoints Andreas Lehmann and Wasim Q. Malik to its Board of Directors, further bolstering depth of commercial industry experience in its leadership and broadening its footprint in the US.

Learn More

ClexBio collaborates with CSEM on automated manufacturing

ClexBio and CSEM, a world-leading public-private technology innovator in Switzerland, have teamed up to develop the world’s first machine capable of growing tissue-engineered human veins in the lab.

Learn More

ClexBio Oversubscribes USD 2.2M Seed Round

ClexBio, a start-up developing bioengineered human blood vessels for transplant, has secured US$2.2m in seed funding from private investors and governmental grants to develop bio-engineered human blood vessel transplants

Learn More

Sphere Fluidics and ClexBio introduce CYTRIX Microfluidic Hydrogel Kit

Sphere Fluidics and ClexBio announce the launch of the CYTRIX Microfluidic Hydrogel Kit. The kit combines ClexBio’s novel CYTRIX Hydrogel with Sphere Fluidics’ Pico-Gen™ double aqueous biochip to allow the plug-and-play generation of reproducible and tailorable hydrogel microstructures for 3D cell culture, organoids, single-cell analysis, and many other applications.

Learn More

ClexBio named Best Healthtech Startup

ClexBio ranked as Best Health Tech startup, Best Newcomer, and CEO Armend G. Håti the Founder of the Year in Norway at the Nordic Start-up Awards 2020.

Learn More
Featured in

We’d love to hear from you. Get in touch.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.